Targets › TYMB
1 program from 1 company in 1 trial: 1 Phase 4; Infectious disease.
Open in Phaseline: the race on TYMB, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| Air Force Specialized Hospital, Cairo, Egypt | Tigecycline Bacterial 70S ribosome inhibitor | TYMB | Phase 4 | Multi Drug Resistant Infections | – |
Multi Drug Resistant Infections (1)
small molecule (1)
Air Force Specialized Hospital, Cairo, Egypt (1)
–
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.